All e-Posters are available to view in the Exhibit Hall B.   The e-posters are in electronic format. There will be a moderated session for e-posters on Saturday evening with the top honor abstracts, followed by a Session on Sunday and one on Monday for some of the best abstracts. Presenters are asked to be at their screen for the entire presentation session.

We suggest that you also download any QR code reader application for your mobile smartphone or tablet.  This will give you the opportunity to scan the QR Code of ePoster of interest from the ePoster touch screens.  If the author has given permission, you will then be able to contact the presenter and/or email yourself a non editable PDF version of the ePoster.

Viewing ‘on demand’

E-Posters can be viewed at leisure any time in the Convention Centre from Saturday to Tuesday during the opening hours.  You may want to be able to select any poster you wish to view “on demand” and on any day/time of the meeting as well.  Meeting personnel will be available at the e-Poster desk in the back of Exhibit Hall B to assist with any questions you may have.

Viewing posters as of Saturday May 5th and after the Congress

All e-posters are available to view online as of Saturday May 5th and will remain available for viewing after the conclusion of the meeting,
via this link http://ispd-library.multilearning.com/

An e-Poster helpdesk will be situated in the back of the Exhibit Hall B.  Feel free to speak to our onsite e-Poster staff to get a tutorial or tips.

Saturday, May 5th, 2018 – 18:30-19:30
For e-poster viewing on Saturday evening, the e-posters are set up by Categories and Screen as indicated below.  All presenters will have 9 minutes to present (incl Q&A) and they will present twice during the session.

SCREEN 1 –  Immunology, Inflammation and Fibrosis in the peritoneum

P-005 BLOCKADE OF THROMBOSPONDIN-1 AMELIORATES HIGH GLUCOSE-INDUCED PERITONEAL FIBROSIS THROUGH DOWN-REGULATION OF TGF-BETA1/SMAD SIGNALING PATHWAY Na Jiang, China
     
P-008 PERITONEAL INFLAMMATION INCREASES OVER TIME, WITH ASSOCIATED INCREASE IN PLASMA IL-6 PREDICTING WORSENING SURVIVAL: RESULTS FROM THE GLOBAL FLUID STUDY Emma Elphick, United Kingdom
     
P-009 A PD DWELL TRIGGERS MECHANORECEPTOR TRPA1, LEADING TO SUBSTANCE P SECRETION THAT INDUCES NK1- MEDIATED IL-6 TRANSCRIPTION IN THE RAT Magnus Braide, Sweden

 

 

SCREEN 2 –  PD Fluids and Treatment Regimens  /  PD Adequacy, Residual Renal Function and Bioimpedence  / Rehabilitation, Psychological Issues, and Socio-economics of PD

P-002 BIOIMPEDANCE-GUIDED FLUID MANAGEMENT CAN IMPROVE CLINICAL OUTCOME IN PERITONEAL DIALYSIS PATIENT: A PROSPECTIVE RANDOMIZED CONTROL TRIAL Na Tian, China
     
P-004 Single or dual use renin-angiotensin system inhibitors on residual renal function in patients receiving continuous ambulatory peritoneal dialysis Fan Li, China
     
P-007 CORRECT START INITIATIVE IMPROVES PERITONEAL DIALYSIS RATES. Nathoo Bharat, Canada

 

SCREEN 3 – Peritoneal Anatomy, Histopathology and Imaging  /  Access, Peritonitis and Exit Site Infections

P-003 PERITONITIS EPISODES DO NOT AFFECT PERITONEAL MEMBRANE TRANSFORMATION Maria Bartosova, Germany
     
P-006 A MULTICENTER, RANDOMIZED, CONTROLLED TRIAL COMPARING CEFEPIME MONOTHERAPY VERSUS COMBINATION OF CEFAZOLIN PLUS CEFTAZIDIME FOR EMPIRICAL ANTIBIOTIC TREATMENT OF PD-ASSOCIATED PERITONITIS Talerngsak Kanjanabuch, Thailand

 

Sunday, May 6th, 2018 – 13:00-13:55     AND   Monday, May 7th, 2018 – 13:10-14:10

During this time only, the screens are set up for the oral e-poster presentations.   All presenters will have 7 minutes to present (incl Q&A).

All the other e-poster abstracts will be viewable on all screens during the day, except the above scheduled presentation times.  You may use any screen to search all the posters by either category, poster number or last name.

 

SCREEN 1 – Immunology, Inflammation and Fibrosis in the peritoneum

P-012 MICRORNA-200C ATTENUATES TGF-BETA1-INDUCED EPITHELIAL-TO-MESENCHYMAL TRANSITION AND MATRIX PROTEIN DEPOSITION IN HUMAN PERITONEAL MESOTHELIAL CELLS Susan Yung, Hong Kong
     
P-016 APOPTOSIS INHIBITOR OF MACROPHAGE PROMOTED ENGULFMENT OF NECROTIC DEBRIS BY MACROPHAGES AND MESOTHELIAL CELLS Yasuhiko Ito, Japan
     
P-017 THE ROLE OF MACROPHAGES IN PERITONEAL FIBROSIS Yi-Ting Chen, Taiwan
     
P-029 DELETION OF CONNECTIVE TISSUE GROWTH FACTOR AMELIORATES PERITONEAL FIBROSIS AND PERITONEAL FUNCTION. Naohiro Toda, Japan
     
P-030 C5A PLAYS SOME ROLES TO DEVELOP SEVERE PERITONEAL INJURIES OF A ZYMOSAN-INDUCED PERITONITIS PRETREATED WITH METHYLGLYOXAL IN RAT Masashi Mizuno, Japan
     
P-044 PROTECTIVE EFFECTS OF ALANYL-GLUTAMINE ON THE PERITONEAL MESOTHELIAL CELL PROTEOME IN A CHRONIC MODEL OF PERITONEAL DIALYSIS Klaus Kratochwill, Austria
     
P-049 BLOCKING THE SUBSTANCE P RECEPTOR NK1 IN PD PATIENTS REDUCES IL-6 RELEASE INTO THE PERITONEAL CAVITY Magnus Braide, Sweden

 

SCREEN 2 – Rehabilitation, Psychological Issues, and Socio-economics of PD   /  Novel clinical indications for PD

P-018 PATIENT PERSPECTIVES ON RENAL REPLACEMENT THERAPY CHOICE IN PERITONEAL VS. HEMODIALYSIS: A MULTICENTER QUESTIONNAIRE STUDY ON BIOETHICAL DIMENSIONS Michael Balzer, Germany
     
P-026 COGNITIVE CHANGES IN PERITONEAL DIALYSIS PATIENTS,  A MULTI-CENTER PROSPECTIVE COHORT STUDY Zhi-kai Yang, China
     
P-028 SOCIOECONOMIC FACTORS AND RACIAL/ETHNIC DIFFERENCES IN PD OUTCOMES Jenny Shen, USA
     
P-032 LET´S TALK ABOUT SEX: PERITONEAL DIALYSIS COULD BE BETTER THAN HEMODIALYSIS FOR SEXUAL HEALTH Rafael Selgas, Spain
     
P-048 INCREASED PERITONEAL DIALYSIS AS INITITAL TREATMENT MODALITY: A COST-UTILITY ANALYSIS Thomas Ferguson, Canada
     
P-023 PREDICTORS OF USING PERITONEAL DIALYSIS AS INITIAL MODALITY AFTER GRAFT FAILURE Sana Waheed, USA
     
P-040 PREDICTORS AND OUTCOMES OF PATIENTS SWITCHING FROM HEMODIALYSIS TO PERITONEAL DIALYSIS IN AUSTRALIA AND NEW ZEALAND – A CASE FOR PD FIRST POLICY Anh Nguyen, Vietnam

 

 

SCREEN 3 – Access, Peritonitis and Exit Site Infections  /  Immunology, Inflammation and Fibrosis in the peritoneum

P-011 THE “CATHETER MODULE” OF THE RDPLF : RESULTS AT 20 YEARS Max Dratwa, Belgium
     
P-024 THE RELATIONSHIP BETWEEN PERITONITIS AND SARCOPENIA IN PERITONEAL DIALYSIS PATIENTS Seok Hui Kang, Republic of Korea
     
P-027 ULINASTATIN – A SAVIOR IN SEPSIS DUE SEVERE PD RELATED PERITONITIS Karapodi Nayak, India
     
P-035 WHETHER TO USE OR NOT PROPHYLACTIC ANTIBIOTICS IN AUTOMATED PERITONEAL DIALYSIS PATIENTS UNDERGOING COLONOSCOPY Mohamed Nasreldin, Saudi Arabia
     
P-022 OUTCOMES OF TRANSPLANT PATIENTS WITH ENCAPSULATING PERITONEAL SCLEROSIS TREATED WITH TAMOXIFEN AND STEROIDS Rajeevalochana Parthasarathy, Canada

 

 

SCREEN 4 – Nutrition, Dietetics and Gut Function in PD patients  /  PD in Older Population /  PD in Paediatric Patients

P-014 ASSESSMENT OF SWALLOWING MUSCLES BY TONGUE PRESSURE MEASUREMENT AND ASSOCIATION WITH MALNUTRITION AND SARCOPENIA IN PERITONEAL DIALYSIS PATIENTS: FROM THE PERSPECTIVE OF ORAL FRAILTY Yuka Kamijo, Japan
     
P-037 THE EFFECT OF LOW POTASSIUM ON INTESTINAL BARRIER AND ITS REGULATION MECHANISM Haishan Wu, China
     
P-038 THE LONG-TERM EFFECT OF REPEATED FLUID STATUS MEASUREMENTS BY BIOIMPEDANCE ANALYSIS IN PERITONEAL DIALYSIS PATIENTS: PROGNOSTIC VALUE OF CHRONIC FLUID OVERLOAD Jwa-Kyung Kim, Republic of Korea
     
P-025 DRIVING EQUITY IN ASSISTED PD MODELS OF CARE THROUGH INTEGRATED FUNDING Karla Houser, Canada
     
P-041 GDF15 PREDICTED CHRONIC FLUID OVERLOAD IN PEDIATRIC PERITONEAL DIALYSIS PATIENTS Hui Kim Yap, Singapore
     
P-045 INCIDENCE OF PERITONITIS IN PAEDIATRIC PATIENTS ON PERITONEAL DIALYSIS: A 10 YEAR TERTIARY CENTRE EXPERIENCE IN SCOTLAND Laura Martin, United Kingdom

SCREEN 5 –  Peritoneal Transport Function and Ultrafiltration  /  Anaemia, Metabolism, and CKD-MBD in PD patients  /  Cardiovascular Complications of PD patients /  PD Adequacy, Residual Renal Function and Bioimpedence /  PD Fluids and Treatment Regimens

P-001 ASSESSMENT OF SWALLOWING MUSCLES BY TONGUE PRESSURE MEASUREMENT AND ASSOCIATION WITH MALNUTRITION AND SARCOPENIA IN PERITONEAL DIALYSIS PATIENTS: FROM THE PERSPECTIVE OF ORAL FRAILTY Ting Sun, Japan
     
P-015 THE EFFECT OF LOW POTASSIUM ON INTESTINAL BARRIER AND ITS REGULATION MECHANISM Marina Vorobiov, Israel
     
P-036 THE LONG-TERM EFFECT OF REPEATED FLUID STATUS MEASUREMENTS BY BIOIMPEDANCE ANALYSIS IN PERITONEAL DIALYSIS PATIENTS: PROGNOSTIC VALUE OF CHRONIC FLUID OVERLOAD Raymond Pratt, USA
     
P-021 DRIVING EQUITY IN ASSISTED PD MODELS OF CARE THROUGH INTEGRATED FUNDING Rebecca Herzog, Austria
     
P-034 GDF15 PREDICTED CHRONIC FLUID OVERLOAD IN PEDIATRIC PERITONEAL DIALYSIS PATIENTS Simon Leclerc, Canada
     
P-020 INCIDENCE OF PERITONITIS IN PAEDIATRIC PATIENTS ON PERITONEAL DIALYSIS: A 10 YEAR TERTIARY CENTRE EXPERIENCE IN SCOTLAND Maria Bartosova, Germany

 

SCREEN 6 –  OPEN SCREEN

Tuesday, May 8th, 2018
All the e-posters are viewable this day on all the 6 screens and are free flow.  You may use any screen to search all the posters by either category, poster number or last name.

Viewing ‘on demand’

E-Posters can be viewed at leisure any time in the Convention Centre from Saturday to Tuesday during the opening hours.  You may want to be able to select any poster you wish to view “on demand” and on any day/time of the meeting as well.  Meeting personnel will be available at the e-Poster desk in the back of Exhibit Hall B to assist with any questions you may have.

Viewing posters as of Saturday May 5th and after the Congress

All e-posters are available to view online as of Saturday May 5th and will remain available for viewing after the conclusion of the meeting,
via this link http://ispd-library.multilearning.com/

Sign Up to Get Updates on ISPD 2018

 

 

Thanks for signing up - check your inbox!